Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.

J Antimicrob Chemother

Institute of Clinical Pharmacology and Toxicology, Department of Experimental and Clinical Pathology and Medicine, Medical School, University of Udine, Udine, Italy.

Published: January 2009

AI Article Synopsis

  • The study aimed to evaluate how well linezolid penetrates bile and its effectiveness against vancomycin-resistant enterococci (VRE) in liver transplant patients treated for severe infections.
  • Researchers collected bile and blood samples from six liver transplant patients after administering linezolid, finding that bile levels of the drug were significantly higher than in plasma.
  • The results indicated that linezolid might be effective in treating infections caused by VRE in bile, although more research is needed to confirm its pharmacodynamic properties.

Article Abstract

Objectives: The aim of the study was to assess the biliary penetration of linezolid and the probabilities of attaining optimal pharmacodynamic exposure against vancomycin-resistant enterococci (VRE) in the bile of liver transplant (LTx) patients who received linezolid for the treatment of multidrug-resistant Gram-positive hospital infections.

Methods: After at least 2 days of standard 600 mg twice-daily therapy, simultaneous bile and blood samples for linezolid assay were collected from six LTx patients just prior to drug administration to determine trough concentrations (Cmin) at steady-state in both sites. Linezolid concentrations in plasma and in bile were analysed by means of HPLC. Biliary penetration of linezolid was calculated as the ratio between Cmin in bile and in plasma. Optimal theoretical pharmacodynamic exposure of linezolid against VRE in bile was defined as biliary Cmin>MIC90.

Results: C(min) of linezolid in bile achieved very high values at steady-state, which were significantly higher than in plasma (median of 21.77 versus 8.08 mg/L, P=0.021). The very high biliary penetration of linezolid (median value of 1.93; range 1.31-4.83) enabled achievement of optimal theoretical pharmacodynamic exposure against VRE in bile (Cmin>2 mg/L) on all of the occasions.

Conclusions: These preliminary data suggest a potential role for linezolid in the treatment of cholangitis due to VRE in LTx patients. Obviously, further confirmatory data assessing also the AUC/MIC ratio of linezolid in bile are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkn442DOI Listing

Publication Analysis

Top Keywords

biliary penetration
16
pharmacodynamic exposure
16
penetration linezolid
12
vre bile
12
ltx patients
12
linezolid
11
exposure linezolid
8
liver transplant
8
bile
8
linezolid treatment
8

Similar Publications

Introduction: Bowel perforation due to migrated biliary stent is a rare complication. Here, we report a case of duodenal and ascending colonal perforation due to biliary stent migration.

Case Presentation: A 35-year-old man is complaining of right upper abdominal pain presented to the gastroenterology department.

View Article and Find Full Text PDF

Light-Directed Self-Powered Metal-Organic Framework Based Nanorobots for Deep Tumor Penetration.

Adv Mater

December 2024

Frontiers Science Centre for High Energy Material, Advanced Technology Research Institute (Jinan), Key Laboratory of Cluster Science (Ministry of Education), Beijing Key Laboratory of Photoelectronic/Electrophotonic Conversion Materials, Advanced Research Institute of Multidisciplinary Science, School of Medical Technology, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, 100081, P. R. China.

Effective intratumoral distribution of anticancer agents with good tumor penetration is of great practical importance for oncotherapy. How to break the limitation of traditional passive drug delivery relying on blood circulatory system into solid tumors remains a challenge. Herein, a light-directed self-powered nanorobot based on zirconium-based porphyrin metal-organic framework (MOF) is reported for smart delivery of chemodrug and photosensitizer for deep tumor penetration.

View Article and Find Full Text PDF

Clinical Features of Impacted Common Bile Duct Stones at Duodenal Papilla.

Korean J Gastroenterol

December 2024

Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Korea.

Background/aims: Urgent endoscopic removal is required for gallstones impacted at the duodenal papilla. This study compared the clinical features of impacted papillary stones (IPS) with those of common bile duct stones without impaction.

Methods: This study analyzed a common bile duct stone database from 2017 to 2023, identifying patients with IPS.

View Article and Find Full Text PDF

Invasive infections impact gut microbiota in a definitive host in Europe.

Int J Parasitol Parasites Wildl

December 2024

Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm, Germany.

Invasive parasites that expand their natural range can be a threat to wildlife biodiversity and may pose a health risk to non-adapted, naive host species. The invasive giant liver fluke, , native to North America, has extended its range in Europe and uses mainly red deer () as definitive hosts. The penetration of the intestinal barrier by the young flukes to reach the liver via the abdominal cavity as well as the release of fluke metabolism products and excreta with the bile and/or changes in the microbial community of the biliary system may enable the translocation of intestinal bacteria across the intestinal barrier and, in turn, could be associated with inflammation and changes in the intestinal bacterial community.

View Article and Find Full Text PDF

Osteosarcoma, a predominant malignant tumor among adolescents, exhibits high mortality and suboptimal immunotherapy efficacy due to a collagen-dense extracellular matrix (ECM) that hinders cytotoxic T lymphocyte (CTL) infiltration. Herein, we developed mesoporous polydopamine (MPDA) nanoparticles encapsulating bromelain and the immune adjuvant R848 (M@B/R), aimed at enhancing photothermal immunotherapy. These nanoparticles efficiently accumulate at the tumor site following injection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!